Search Results - "Bock, Matthew"

Impact of race and health coverage on listing and waitlist mortality in pediatric cardiac transplantation by Strah, Danielle, Bock, Matthew J.

Get full text

Rapid, Homogenous, B‑Alkyl Suzuki–Miyaura Cross-Coupling of Boronic Esters by Bock, Matthew J., Denmark, Scott. E.

“…A rapid, anhydrous Suzuki–Miyaura cross-coupling of alkylboronic esters with aryl halides is described. Parallel experimentation revealed that the combination…”
Get full text

Organ transplantation using COVID‐19‐positive deceased donors by Bock, Matthew J., Vaughn, Gabrielle R., Chau, Peter, Berumen, Jennifer A., Nigro, John J., Ingulli, Elizabeth G.

“…The COVID‐19 pandemic has influenced organ transplantation decision making. Opinions regarding the utilization of coronavirus disease‐2019 (COVID‐19) donors…”
Get full text

COVID-19 diagnosis and testing in pediatric heart transplant recipients by Bock, Matthew J., Kuhn, Micheal A., Chinnock, Richard E.

“…Pediatric heart transplant recipients have been expected to be at higher risk of adverse events from developing COVID-19 infection. COVID-19 RNA PCR and…”
Get full text

Transition from intravenous treprostinil to enteral selexipag in an infant with pulmonary arterial hypertension by Koo, Rachel, Lo, Jennifer, Bock, Matthew J

“…Selexipag is an enteral, selective prostacyclin IP receptor agonist approved for pulmonary hypertension in adults. There are few reports of its use in children…”
Get more information

Effects of universal critical CHD screening of neonates at a mid-sized California congenital cardiac surgery centre by Miller, Robin, Martens, Timothy, Jodhka, Upinder, Tran, Jade, Lion, Richard, Bock, Matthew J

“…CHD affects over 1 million children in the United States. Studies show decreased mortality from CHD with newborn cardiac screening. California began a…”
Get more information

The teammate trial: Study design and rationale tacrolimus and everolimus against tacrolimus and MMF in pediatric heart transplantation using the major adverse transplant event (MATE) score by Almond, Christopher S., Sleeper, Lynn A., Rossano, Joseph W., Bock, Matthew J., Pahl, Elfriede, Auerbach, Scott, Lal, Ashwin, Hollander, Seth A., Miyamoto, Shelley D., Castleberry, Chesney, Lee, Joanne, Barkoff, Lynsey M., Gonzales, Selena, Klein, Gloria, Daly, Kevin P.

“…Currently there are no immunosuppression regimens FDA-approved to prevent rejection in pediatric heart transplantation (HT). In recent years, everolimus (EVL)…”
Get full text

Primary Transplantation for Congenital Heart Disease in the Neonatal Period: Long-term Outcomes by John, Mohan M., Razzouk, Anees J., Chinnock, Richard E., Bock, Matthew J., Kuhn, Michael A., Martens, Timothy P., Bailey, Leonard L.

“…Primary transplantation was developed in the 1980s as an alternative therapy to palliative reconstruction of uncorrectable congenital heart disease. Although…”
Get full text

Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind Trial by Shaddy, Robert, Burch, Michael, Kantor, Paul F, Solar-Yohay, Susan, Garito, Tania, Zhang, Sijia, Kocun, Michele, Mao, Chad, Cilliers, Antoinette, Wang, Xu, Canter, Charles, Rossano, Joseph, Wallis, Gonzalo, Menteer, Jondavid, Daou, Linda, Kusa, Jacek, Tokel, Kursat, Dilber, Daniel, Xu, Zhuoming, Xiao, Tingting, Halnon, Nancy, Daly, Kevin P, Bock, Matthew J, Zuckerman, Warren, Singh, Tajinder P, Chakrabarti, Manisha, Levitas, Aviva, Senni, Michele, Grutter, Giorgia, Kim, Gi Beom, Song, Jinyoung, Lee, Hyoung Doo, Chen, Ching Kit, Sanchez-de-Toledo, Joan, Law, Yuk, Wanitkun, Suthep, Cui, Yanqin, Anjos, Rui, Mese, Timur, Bonnet, Damien

“…Sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor (ARNI), is an established treatment for heart failure (HF) with reduced left ventricular…”
Get full text

Fontan‐associated plastic bronchitis waitlist and heart transplant outcomes: A PHTS analysis by Bearl, David W., Cantor, Ryan, Koehl, Devin, Gossett, Jeffrey G., Bock, Matthew J., Halnon, Nancy, Glass, Lauren, Exil, Vernat, Musselwhite, Courtney, Kirklin, James K., Godown, Justin, Ravishankar, Chitra

“…Plastic bronchitis is a rare post‐Fontan complication with limited treatment options. Heart transplantation has evolved as a potential curative option, but…”
Get full text

Donor-recipient height ratio and outcomes in pediatric heart transplantation by Patel, Anjlee, Bock, Matthew J., Wollstein, Adi, Nguyen, Khanh, Malerba, Stefano, Lytrivi, Irene D.

“…Height matching in pediatric HTx has been proposed as a superior method of evaluating graft size, but no studies have examined survival advantage for…”
Get full text

Risk Factors for Cardiac and Non-cardiac Causes of Death in Males with Duchenne Muscular Dystrophy by Wittlieb-Weber, Carol A., Knecht, Kenneth R., Villa, Chet R., Cunningham, Chentel, Conway, Jennifer, Bock, Matthew J., Gambetta, Katheryn E., Lal, Ashwin K., Schumacher, Kurt R., Law, Sabrina P., Deshpande, Shriprasad R., West, Shawn C., Friedland-Little, Joshua M., Lytrivi, Irene D., McCulloch, Michael A., Butts, Ryan J., Weber, David R., Johnson, Jonathan N.

“…As survival and neuromuscular function in Duchenne muscular dystrophy (DMD) have improved with glucocorticoid (GC) therapy and ventilatory support, cardiac…”
Get full text

Elective left pulmonary artery embolisation for pulmonary arteriovenous malformations secondary to cavopulmonary anastomoses not responsive to heart transplantation: a case report by Bebawy, Caroline M, Gordon, Brent M, Bock, Matthew J

“…A 10-year-old female with heterotaxy-asplenia and complex CHD developed pulmonary arteriovenous malformations with associated cyanosis after Fontan completion…”
Get more information

The Effect of Infectious Complications During Ventricular Assist Device Use on Outcomes of Pediatric Heart Transplantation by Auerbach, Scott. R., Cantor, Ryan S., Bradford, Tamara T., Bock, Matthew J., Skipper, Eric R., Koehl, Devin A., Butler, Kathleen, Alejos, Juan. C., Edens, R. Erik, Kirklin, James K.

“…To describe the impact of infectious adverse events (IAEs) during ventricular assist device (VAD) support on graft loss, infection, and rejection after…”
Get full text

Diversity of Dystrophin Gene Mutations and Disease Progression in a Contemporary Cohort of Duchenne Muscular Dystrophy by Gambetta, Katheryn E., McCulloch, Michael A., Lal, Ashwin K., Knecht, Kenneth, Butts, Ryan J., Villa, Chet R., Johnson, Jonathan N., Conway, Jennifer, Bock, Matthew J., Schumacher, Kurt R., Law, Sabrina P., Friedland-Little, Joshua M., Deshpande, Shriprasad R., West, Shawn C., Lytrivi, Irene D., Wittlieb-Weber, Carol A.

“…Abnormal dystrophin production due to mutations in the dystrophin gene causes Duchenne Muscular Dystrophy (DMD). Cases demonstrate considerable genetic and…”
Get full text

Cancer recurrence and mortality after pediatric heart transplantation for anthracycline cardiomyopathy: A report from the Pediatric Heart Transplant Study (PHTS) group by Bock, Matthew J., Pahl, Elfriede, Rusconi, Paolo G., Boyle, Gerard J., Parent, John J., Twist, Clare J., Kirklin, James K., Pruitt, Elizabeth, Bernstein, Daniel

“…We aimed to determine whether malignancy after pediatric HTx for ACM affects overall post‐HTx survival. Patients <18y listed for HTx for ACM in the PHTS…”
Get full text

Congenitally "Inverted" Pulmonary Valve in Tetralogy of Fallot: When Nature Falters by Jhaveri, Simone, Parness, Ira, Geva, Tal, Bock, Matthew J, Love, Barry, Srivastava, Shubhika

“…A cyanotic neonate with tetralogy of Fallot was found to have a congenitally inverted pulmonary valve. Diagnosis was made via echocardiography and cardiac…”
Get full text

Pediatric cardiac retransplantation: Waitlist mortality stratified by age and era by Bock, Matthew J., MD, Nguyen, Khanh, MD, Malerba, Stefano, MS, Harrison, Kimberly, CPNP, Bagiella, Emilia, PhD, Gelb, Bruce D., MD, Pinney, Sean P., MD, Lytrivi, Irene D., MD

“…Background Waitlist mortality among children listed for primary heart transplant (HTx) has been well characterized, whereas limited data exist for cardiac…”
Get full text

Implantable Cardioverter Defibrillator Use in Males with Duchenne Muscular Dystrophy and Severe Left Ventricular Dysfunction by McCulloch, Michael A., Lal, Ashwin K., Knecht, Kenneth, Butts, Ryan J., Villa, Chet R., Johnson, Jonathan N., Conway, Jennifer, Bock, Matthew J., Schumacher, Kurt R., Law, Sabrina P., Friedland-Little, Joshua M., Deshpande, Shriprasad R., West, Shawn C., Lytrivi, Irene D., Gambetta, Katheryn E., Wittlieb-Weber, Carol A.

“…Duchenne muscular dystrophy (DMD) is characterized by myocardial fibrosis and left ventricular (LV) dysfunction. Implantable cardioverter defibrillator (ICD)…”
Get full text

Reprogramming of human peripheral blood mononuclear cells into induced mesenchymal stromal cells using non-integrating vectors by Chen, Wanqiu, Wang, Chenguang, Yang, Zhi-Xue, Zhang, Feng, Wen, Wei, Schaniel, Christoph, Mi, Xianqiang, Bock, Matthew, Zhang, Xiao-Bing, Qiu, Hongyu, Wang, Charles

“…Mesenchymal stromal cells (MSCs) have great value in cell therapies. The MSC therapies have many challenges due to its inconsistent potency and limited…”
Get full text